ABN AMRO Bank N.V. Sells 59,220 Shares of MetLife, Inc. $MET

Key Points

• ABN AMRO Bank N.V. trimmed its MetLife stake by 2.6% in the fourth quarter, selling 59,220 shares and leaving it with 2,186,950 shares worth about $172.5 million. MetLife remained one of the bank’s larger holdings, representing roughly 1.6% of its portfolio.
• MetLife reported solid quarterly results, posting EPS of $2.42 versus the $2.27 consensus, though revenue came in below expectations at $14.18 billion. The company also said revenue rose 2.7% year over year and analysts now expect full-year EPS of 9.89.
• The insurer raised its dividend to $0.5925 per share quarterly, equal to a $2.37 annualized payout and a 3.0% yield. Wall Street remains broadly positive, with a consensus rating of Moderate Buy and an average target price of $93.85.

ABN AMRO Bank N.V. reduced its position in shares of MetLife, Inc. (NYSE:MET - Free Report) by 2.6% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 2,186,950 shares of the financial services provider's stock after selling 59,220 shares during the quarter. MetLife makes up about 1.6% of ABN AMRO Bank N.V.'s holdings, making the stock its 23rd biggest holding. ABN AMRO Bank N.V. owned about 0.33% of MetLife worth $172,486,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in MET. Vanguard Group Inc. raised its holdings in MetLife by 12.1% in the 4th quarter. Vanguard Group Inc. now owns 72,555,335 shares of the financial services provider's stock worth $5,727,518,000 after purchasing an additional 7,805,814 shares in the last quarter. Dodge & Cox raised its holdings in MetLife by 0.9% in the 3rd quarter. Dodge & Cox now owns 53,659,664 shares of the financial services provider's stock worth $4,419,947,000 after purchasing an additional 477,783 shares in the last quarter. Wellington Management Group LLP raised its holdings in MetLife by 1.5% in the 3rd quarter. Wellington Management Group LLP now owns 12,572,807 shares of the financial services provider's stock worth $1,035,622,000 after purchasing an additional 180,683 shares in the last quarter. Pzena Investment Management LLC raised its holdings in MetLife by 5.8% in the 3rd quarter. Pzena Investment Management LLC now owns 9,672,023 shares of the financial services provider's stock worth $796,685,000 after purchasing an additional 527,388 shares in the last quarter. Finally, Ameriprise Financial Inc. raised its holdings in MetLife by 4.8% in the 3rd quarter. Ameriprise Financial Inc. now owns 7,746,341 shares of the financial services provider's stock worth $640,357,000 after purchasing an additional 352,395 shares in the last quarter. 94.99% of the stock is currently owned by institutional investors.

MetLife Stock Performance

Shares of MET stock opened at $78.08 on Monday. The company has a debt-to-equity ratio of 0.53, a quick ratio of 0.20 and a current ratio of 0.20. The company has a market capitalization of $50.24 billion, a price-to-earnings ratio of 15.13, a price-to-earnings-growth ratio of 0.69 and a beta of 0.78. The company's 50-day moving average is $73.33 and its 200 day moving average is $76.53. MetLife, Inc. has a one year low of $67.33 and a one year high of $83.85.

MetLife (NYSE:MET - Get Free Report) last posted its earnings results on Wednesday, May 6th. The financial services provider reported $2.42 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.27 by $0.15. The business had revenue of $14.18 billion for the quarter, compared to analysts' expectations of $19.49 billion. MetLife had a net margin of 4.66% and a return on equity of 22.60%. The business's revenue for the quarter was up 2.7% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.96 EPS. Sell-side analysts expect that MetLife, Inc. will post 9.89 EPS for the current fiscal year.

MetLife Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, June 9th. Shareholders of record on Tuesday, May 12th will be paid a dividend of $0.5925 per share. The ex-dividend date is Tuesday, May 12th. This represents a $2.37 annualized dividend and a yield of 3.0%. This is an increase from MetLife's previous quarterly dividend of $0.57. MetLife's dividend payout ratio (DPR) is currently 43.99%.

Wall Street Analyst Weigh In

A number of analysts have recently weighed in on MET shares. Bank of America reduced their target price on shares of MetLife from $103.00 to $99.00 and set a "buy" rating on the stock in a research report on Tuesday, April 14th. Barclays upped their target price on shares of MetLife from $89.00 to $93.00 and gave the stock an "overweight" rating in a research report on Thursday. Keefe, Bruyette & Woods reaffirmed a "moderate buy" rating and issued a $87.00 target price on shares of MetLife in a research report on Thursday, March 26th. Weiss Ratings upgraded shares of MetLife from a "hold (c+)" rating to a "buy (b-)" rating in a report on Friday, May 1st. Finally, Evercore set a $96.00 target price on shares of MetLife in a report on Thursday, April 9th. One equities research analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and two have assigned a Hold rating to the stock. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average target price of $93.85.

Trending Headlines about MetLife

Here are the key news stories impacting MetLife this week:

• Positive Sentiment: MetLife reported Q1 2026 EPS of $2.42, beating Wall Street’s $2.27 estimate, with strength tied to higher investment income, underwriting gains, and solid growth in group benefits and Asia business. Article: MET Tops Q1 EPS Estimates on Strong Investment Income and Volume Growth
• Positive Sentiment: Reuters and Bloomberg highlighted that MetLife’s quarterly profit jumped, helped by better PE returns and strong demand in Asia, reinforcing the view that core earnings momentum remains healthy. Article: Insurer MetLife's quarterly profit jumps on strong Asia demand
• Positive Sentiment: MetLife’s earnings call summary and presentation emphasize improving operating performance and strong first-quarter financial results, which may continue to support sentiment around the stock. Article: MetLife, Inc. Q1 2026 Earnings Call Summary
• Neutral Sentiment: News that MetLife Stadium is replacing turf with natural grass ahead of World Cup matches is tied to the venue, not MetLife’s insurance business, so it is unlikely to have a direct impact on the company’s stock. Article: Grass installation starts at MetLife Stadium ahead of World Cup
• Neutral Sentiment: Additional stadium and World Cup logistics coverage, including pitch installation and transit pricing, looks more relevant to event operations than MetLife’s fundamentals. Article: NJ Transit lowers price to $105 for train tickets to World Cup games at MetLife Stadium
• Negative Sentiment: The main offset in the earnings release was a revenue miss versus expectations, which could cap upside if investors decide earnings strength was driven more by favorable investment returns than by top-line growth. Article: NJ Transit lowers World Cup train ticket prices from NYC to MetLife — and it’s still an 800% markup

MetLife Profile

MetLife, Inc is a global provider of insurance, annuities and employee benefit programs. Headquartered in New York City, the company offers a range of risk protection and retirement solutions to individuals, employers and institutional clients. Its core businesses include life insurance, group benefits, retirement products such as annuities, and supplemental health products including dental and disability coverage.

In addition to traditional life and group insurance, MetLife provides workplace benefits and voluntary products distributed through employer-sponsored programs.

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.